HealthQuill hypertension
Researchers have added two additional risk factors — untreated vision loss and high LDL cholesterol — to 12 other steps to identify dementia, projected to affect 153 million people by 2050.
Drugs Health Pharma

Untreated vision loss, high LDL cholesterol risk factors for dementia

Researchers have added two additional risk factors — untreated vision loss and high LDL cholesterol — to 12 other steps to identify dementia,.

Read More
June 27, 2024: Novo Nordisk’s end-stage trial for hypertension drug has failed to meet its primary goal and the Danish multinational has recognised an impairment loss of 5.7 Danish crowns or $817 million in the second quarter of this year.
Drugs Health Pharma

Novo’s end-stage hypertension trial drug fails, $817m impairment loss

Novo Nordisk’s end-stage trial for hypertension drug has failed to meet its primary goal and the Danish multinational has recognised an impairment loss.

Read More
The US regulator, the Food and Drug Administration, has approved Winrevair therapy of Merck & Co., Inc., to treat pulmonary arterial hypertension.
Drugs Health Pharma

US regulator clears Merck’s lung therapy after ‘significant’ results

 HQ Team March 27, 2024: The US regulator, the Food and Drug Administration, has approved Winrevair therapy of Merck & Co., Inc., to.

Read More
Lowering sodium intake can reduce blood pressure regardless of whether one is on medication, a study reveals.
Drugs Health Medical

Salt substitutes effective in reducing hypertension in elderly people

HQ Team February 13, 2024: Adding to the long line of evidence that reducing salt intake affects blood pressure is the latest study.

Read More
Otsuka Medical Devices Co., announced its treatment for hypertension has got approval from the US Food and Drug Administration.
Health Medical Pharma

Otsuka Medical gets USFDA nod for treatment of hypertension  

Otsuka Medical Devices Co., announced its treatment for hypertension has got approval from the US Food and Drug Administration.

Read More
Drugs Health Pharma

Novo Nordisk to buy hypertension drug from KBP for $1.3 billion

HQ Team October 16, 2023: Danish pharmaceutical company, Novo Nordisk, announced it was buying a hypertension drug, still in trials, from Singapore-based KBP.

Read More
More than 1,000 people globally die of strokes and heart attacks every hour, mostly due to high blood pressure, an official of not-for-profit, Resolve to Save Lives, said.
Drugs Health Pharma

‘Every hour 1,000 people die of stroke, heart attack due to high blood pressure’

HQ Team September 19, 2023: More than 1,000 people globally die of strokes and heart attacks every hour, mostly due to high blood.

Read More
Johnson & Johnson has decided to halt an experimental trial, in its final stages, on a drug to treat a form of hypertension, according to a company statement.
Drugs Health Pharma

J&J halts final phase of trials of a drug to treat hypertension, says “futile” 

HQ Team September 7, 2023: Johnson & Johnson has decided to halt an experimental trial, in its final stages, on a drug to.

Read More
Japan’s radiologists using chest radiographs developed an AI model to accurately predict a human’s chronological age and detect chronic diseases.
Drugs Health Pharma

Japan’s radiologists invent AI model to predict age from chest graphs 

HQ Team August 18, 2023: Japan’s radiologists using chest radiographs developed an AI model to accurately predict a human’s chronological age and detect.

Read More
Switzerland’s healthcare company, Roche, signed a pact with US-based Alnylam to jointly develop and commercialize a therapy to treat hypertension in people with high cardiovascular risk.
Drugs Health Pharma

Roche, Alnylam to jointly develop hypertension therapy

HQ Team July 25, 2023: Switzerland’s healthcare company, Roche, signed a pact with US-based Alnylam to jointly develop and commercialize a therapy to.

Read More
X